The fastest-growing region is expected to be Asia Pacific, with a regional forecast indicating a significant increase in market share, driven by emerging economies such as China and India. This region is anticipated to account for around 30% of the market share, with key drivers including increasing adoption of advanced cell dissociation techniques, growing infrastructure for life sciences research, and rising investments in biotechnology. Europe is expected to account for around 20% of the market share, driven by its strong biotechnology industry and high adoption rates of cell dissociation techniques. Latin America and Middle East & Africa are expected to account for around 10% and 5% of the market share, respectively, with key drivers including growing demographics of researchers and scientists, and increasing investments in life sciences research.